Brief: Can-Fite Received Notice Of Allowance From The European Patent Office For The Treatment Of Erectile Dysfunction With Cf602
06/05/2024 12:40
May 6 (Reuters) - Can Fite Biopharma Ltd CANF.TA :
* CAN-FITE RECEIVED NOTICE OF ALLOWANCE FROM THE EUROPEAN
PATENT
OFFICE FOR THE TREATMENT OF ERECTILE DYSFUNCTION WITH CF602
Source text for Eikon: ID:nBw24sSm5a
Further company coverage: CANF.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Can Fite Biopharma
See all newsBrief: Corrected-Can Fite Biopharma Ltd Files For Offering Of Up To 6.6 mln Ordinary Shares By Selling Shareholders
Can-Fite BioPharma rises after longer-than-anticipated overall survival in ongoing liver cancer study
Can-Fite BioPharma reports longer-than-anticipated overall survival in ongoing liver cancer study
Brief: Can Fite Biopharma Can-Fite Submits Phase 2 Study Protocol For Piclidenoson In Lowe Syndrome
Can-Fite rises as skin drug study reaches interim analysis stage